Mitochondrial abnormalities in inclusion-body myositis

Mitochondrial changes are frequently encountered in sporadic inclusion-body myositis (s-IBM). Cytochrome c oxidase (COX)-deficient muscle fibers and large-scale mitochondrial DNA (mtDNA) deletions are more frequent in s-IBM than in age-matched controls. COX deficient muscle fibers are due to clonal expansion of mtDNA deletions and point mutations in segments of muscle fibers. Such segments range from 75 μm to more than 1,000 μm in length. Clonal expansion of the 4977 bp “common deletion” is a frequent cause of COX deficient muscle fiber segments, but many other deletions also occur. The deletion breakpoints cluster in a few regions that are similar to what is found in human mtDNA deletions in general. Analysis in s-IBM patients of three nuclear genes associated with multiple mtDNA deletions, POLG1, ANT1 and C10orf2, failed to demonstrate any mutations. In s-IBM patients with high number of COX-deficient fibers, the impaired mitochondrial function probably contribute to muscle weakness and wasting. Treatment that has positive effects in mitochondrial myopathies may be tried also in s-IBM.

[1]  A. Oldfors,et al.  Inclusion body myositis: morphological clues to correct diagnosis , 2002, Neuromuscular Disorders.

[2]  K. Nagaraju,et al.  The Inhibition of Apoptosis in Myositis and in Normal Muscle Cells1 , 2000, The Journal of Immunology.

[3]  S. Dimauro,et al.  Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. , 1994, Human molecular genetics.

[4]  G Serratrice,et al.  31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies , 1992, Neurology.

[5]  S. Dimauro,et al.  The genetics and pathology of oxidative phosphorylation , 2001, Nature Reviews Genetics.

[6]  Richard J. Barohn,et al.  Inclusion body myositis , 2000, Current treatment options in neurology.

[7]  A. Pestronk,et al.  Inflammatory myopathy with cytochrome oxidase negative muscle fibers: Methotrexate treatment , 1998, Muscle & nerve.

[8]  S. Dimauro,et al.  Mitochondrial encephalomyopathies. , 1989, Progress in clinical and biological research.

[9]  S. McKiernan,et al.  Mitochondrial DNA Deletion Mutations and Sarcopenia , 2002, Annals of the New York Academy of Sciences.

[10]  N. Larsson,et al.  Mitochondrial myopathies. , 2001, Acta physiologica Scandinavica.

[11]  A. Pestronk,et al.  Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. , 1997, Brain : a journal of neurology.

[12]  W. Engel,et al.  Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. van Broeckhoven,et al.  Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA. , 2004, Nucleic acids research.

[14]  A. Schapira.  Mitochondrial myopathies. , 1989, BMJ.

[15]  Z. Simmons,et al.  Sporadic inclusion body myositis and hereditary inclusion body myopathy. , 2002, Journal of clinical neuromuscular disease.

[16]  J. Müller‐Höcker.  Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: An age-related alteration , 1990, Journal of the Neurological Sciences.

[17]  E. Schon,et al.  Two direct repeats cause most human mtDNA deletions. , 2004, Trends in genetics : TIG.

[18]  C. Münscher,et al.  The point mutation of mitochondrial DNA characteristic for MERRF disease is found also in healthy people of different ages , 1993, FEBS letters.

[19]  E. Shoubridge,et al.  Gene shifting: a novel therapy for mitochondrial myopathy. , 1999, Human molecular genetics.

[20]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[21]  R. Carrozzo,et al.  Maternally‐inherited Leigh syndrome‐related mutations bolster mitochondrial‐mediated apoptosis , 2004, Journal of neurochemistry.

[22]  Howard T. Jacobs,et al.  Premature ageing in mice expressing defective mitochondrial DNA polymerase , 2004, Nature.

[23]  W. Engel,et al.  beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. , 1993, Neuroreport.

[24]  P. Nagley,et al.  Age-related human mtDNA deletions: a heterogeneous set of deletions arising at a single pair of directly repeated sequences. , 1994, American journal of human genetics.

[25]  A Seller,et al.  Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. , 1998, Brain : a journal of neurology.

[26]  H. Mandel,et al.  Depletion of the other genome-mitochondrial DNA depletion syndromes in humans , 2002, Journal of Molecular Medicine.

[27]  D. Wallace.  Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.

[28]  Kristian Borg,et al.  Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. , 2003, Journal of rehabilitation medicine.

[29]  S. Dimauro,et al.  Medicinal and genetic approaches to the treatment of mitochondrial disease. , 2003, Current medicinal chemistry.

[30]  P. Nagley,et al.  Multiple mitochondrial DNA deletions in an elderly human individual , 1992, FEBS letters.

[31]  S. Dimauro,et al.  Mitochondrial Encephalomyopathies: Therapeutic Approach , 2004, Annals of the New York Academy of Sciences.

[32]  Jeong W. Pak,et al.  Mitochondrial DNA mutations as a fundamental mechanism in physiological declines associated with aging , 2003, Aging cell.

[33]  E. Holme,et al.  Mitochondrial DNA Deletions in Muscle Fibers in Inclusion Body Myositis , 1995, Journal of neuropathology and experimental neurology.

[34]  J. Schröder,et al.  Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions , 1998, Acta Neuropathologica.

[35]  M. Fardeau,et al.  Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function , 2002, Neuromuscular Disorders.

[36]  W. Engel,et al.  β‐Amyloid precursor epitopes in muscle fibers of inclusion body myositis , 1993 .

[37]  E. Shoubridge,et al.  Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis. , 1998, Journal of neuropathology and experimental neurology.

[38]  Margaret A. Johnson,et al.  Role of mitochondrial DNA mutations in human aging: Implications for the central nervous system and muscle , 1998, Annals of neurology.

[39]  S. Dimauro,et al.  Mitochondrial diseases. , 1989, Neurologic clinics.

[40]  N. Chu,et al.  Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. , 1997, European neurology.

[41]  A. Oldfors,et al.  Analysis of multiple mitochondrial DNA deletions in inclusion body myositis , 1997, Human mutation.

[42]  T Yamamoto,et al.  High-dose vitamin C therapy for inclusion body myositis. , 2001, Fukuoka igaku zasshi = Hukuoka acta medica.

[43]  R. Hohlfeld,et al.  Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. , 1997, Brain : a journal of neurology.

[44]  M. Falkenberg,et al.  Reconstitution of a minimal mtDNA replisome in vitro , 2004, The EMBO journal.

[45]  E. Holme,et al.  Mitochondrial DNA deletions in inclusion body myositis. , 1993, Brain : a journal of neurology.

[46]  A. Oldfors,et al.  Expression of Bcl‐2 in inclusion body myositis , 2002, Acta neurologica Scandinavica.

[47]  G. Comi,et al.  Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria , 2001, Nature Genetics.

[48]  E. Shoubridge,et al.  Aerobic conditioning in patients with mitochondrial myopathies: Physiological, biochemical, and genetic effects , 2001, Annals of neurology.

[49]  E. Holme,et al.  Autosomal dominant progressive external ophthalmoplegia , 1999, Neurology.

[50]  P. Tonin,et al.  T-cell anti-apoptotic mechanisms in inflammatory myopathies , 2000, Journal of Neuroimmunology.

[51]  A. Eisen,et al.  Inclusion body myositis , 1978, Neurology.

[52]  C. Broeckhoven,et al.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions , 2001, Nature Genetics.

[53]  S. Welle,et al.  Ragged Red Fibers in Normal Aging and Inflammatory Myopathy , 1995, Annals of neurology.

[54]  Margaret A. Johnson,et al.  Reversal of a mitochondrial DNA defect in human skeletal muscle , 1997, Nature Genetics.

[55]  S. Dimauro,et al.  Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients , 1996, Annals of neurology.

[56]  E. Holme,et al.  Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia , 1996, Annals of neurology.

[57]  M. Nakagawa,et al.  Apoptosis is suspended in muscle of mitochondrial encephalomyopathies , 2002, Acta Neuropathologica.

[58]  L. Peltonen,et al.  Role of adenine nucleotide translocator 1 in mtDNA maintenance. , 2000, Science.

[59]  E. Shoubridge,et al.  Late‐onset mitochondrial myopathy , 1995, Annals of neurology.

[60]  N. Ashley,et al.  Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. , 2004, Human molecular genetics.

[61]  W. Engel,et al.  beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. , 1993, Annals of neurology.

[62]  P. Nagley,et al.  Mutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing. , 1998, Nucleic acids research.

[63]  Kucharz Ej.  [Inclusion body myositis]. , 1998, Polskie Archiwum Medycyny Wewnetrznej.